Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. (Q38484886)
Jump to navigation
Jump to search
scientific article published on June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. |
scientific article published on June 2015 |
Statements
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC (English)
Aleksandar Sekulic
Michael R Migden
Karl Lewis
James A Solomon
Simon Yoo
Philip A Friedlander
Ellen Marmur
Anne Lynn S Chang
Luc Dirix
Jeannie Hou
Huibin Yue
ERIVANCE BCC investigators